Carcinoma in situ (CIS) of the testis

Acta Biomedica

Volumn 82, Issue 2, 2011, Pages 162-169

  Ziglioli, Francesco ^a   Maestroni, Umberto ^a   Dinale, Francesco ^a   Ciuffreda, Matteo ^a   Cortellini, Pietro ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

CIS testis; Infertility; Testicular biopsies; Testicular cancer

Indexed keywords

CISPLATIN;

ARTICLE; CANCER RADIOTHERAPY; CARCINOGENESIS; CARCINOMA IN SITU; CLINICAL FEATURE; FOLLOW UP; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; MALE FERTILITY; ORCHIECTOMY; PREVALENCE; RADIATION DOSE; RISK FACTOR; TESTIS BIOPSY; TESTIS CARCINOMA; TESTIS CARCINOMA IN SITU; GENETICS; MALE; REVIEW; TESTIS TUMOR;

CARCINOMA IN SITU; HUMANS; MALE; RISK FACTORS; TESTICULAR NEOPLASMS;

EID: 84860546103     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Hoei-Hansen CE, Rajpert-Demeyts E, Daugaard G. Carcinoma in situ, the progenitor of germ cell tumour: a clinical review. Ann Onc 2005; 16: 863-8.
2. Skakkebæk NE. Possible carcinoma in situ of the testis. Lancet 1972; 2: 516-7.
3. Gondos B, Berthelsen JG, Skakkebæk NE. Intratubular germ cell neoplasia (carcinoma in situ): a preinvasive lesion of the testis. Ann Clin Lab Sci 1983; 13: 185-92.
4. Loy V, Dieckmann KP. Carcinoma in situ of the testis: intratubular germ cell neoplasia or testicular intraepithelial neoplasia? Hum Pahol 1990; 21: 457-8.
5. Gouveia Bazao CA, Pierik FH, Oosterhuis JW, Dohle GR, Looijenga LH, Weber RF. Bilateral testicular microlithiasis predicts the presence of the precursor of testicular germ cell tumour in subfertile men. J Urol 2004; 171: 158-60.
6. Hoei-Hansen CE, Hol M, Rajpert-Demeyts E, Skakkebæk NE. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. J Pathol 2003; 200: 370-4.
7. Giwercman A, Bruun E, Frimodt-Moller C, Skakkebæk NE. Prevalence of carcinoma in situ and other histopathological abnormalities in testes in men with a history of criptorchidism. J Urol 1989; 142: 998-1001.
8. von der Maase H, Gwercman A, Müller J, Skakkebæk NE. Management of the carcinoma in situ of the testis. Int J Androl 1987; 10: 209-20.
9. Christensen TB, Daugaard G, Geertsen PF, von der Maase H. Effect of chemotherapy on carcinoma in situ of the testis. Ann Onc 1998; 9: 657-60.
10. Dieckmann KP, Pichleimer U. Clinical epidemiology of testicular germ cell tumours. World J Urol 2004; 22: 2-14.
11. Slowikowska-Hilczer J, Romer TE, Kula K. Neoplastic potential of germ cell in relation to disturbances of gonadal organogenesis and change in kariotype. J Androl 2003; 24: 270-8.
12. Weir HK, Marrett LD, Kreiger N, Darlington GA, Sugar L. Pre-natal and peri-natal exposure and risk of testicular germ cell cancer. Int J Cancer 2000; 87: 438-43.
13. English PB, Goldberg DE, Wolff C, Smith D. Parental and birth characteristics in relation to testicular cancer risk among males born between 1960 and 1995 in California (United States). Cancer Causes Control 2003; 14: 815-25.
14. Sharpe RM, Franks S. Environment, lifestyle and infertility? An inter-generational issue. Nat Med 2002; 8 (Suppl. 2): S33-S40.
15. Rajpert-Demeyts E, Jørgensen N, Brøndum-Nielsen K, Müller J, Skakkebæk NE. Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS 1998; 106: 198-204.
16. Skakkebæk NE, Rajpert-Demeyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001; 16: 972-8.
17. Hardell L, van Bavel B, Lindstrom G, et al. Increased concentration of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer. Environ Health Perspect 2003; 111: 930-4.
18. Fosså SD, Aass N, Heilo A, et al. Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy. Ann Onc 2003; 14: 1412-8.
19. Hartmann JT, Fosså SD, Nichols CR, et al. Incidence of metachronous testicular cancer in patients with extragonadal germ-cell tumour. J Natl Cancer Inst 2001; 93: 1733-8.
20. Hoei-Hansen CE, Nielsen JE, Almstrup K, Hansen MA, Skakkebæk NE, Rajpert-Demeyts E. Identification of genes differentially expressed in testes containing carcinoma in situ. Mol Hum Reprod 2004; 10 (6): 423-31.
21. Almstrup K, Ottensen AM, Sonne SB, et al. Genomic and gene expression signature of the pre-invasive testicular carcinoma in situ. Cell Tiss Res 2005; 322: 159-65.
22. Hoei-Hansen CE, Nielsen JE, Almstrup K, et al. Transcription of AP-2γ is a developmentally regulated novel marker of testicular carcinoma in situ and germ cell tumours. Clin Cancer Res 2004; 10: 8521-30.
23. Almstrup K, Hoei-Hansen CE, Wirkner U, et al. Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Research 2004; 64: 4736-43.
24. Pauls K, Jager R, Weber S, et al. Transcription factor AP-2gamma, a novel marker of gonocytes and seminomatous germ cell tumours. Int J Canc 2005; 115: 470-7.
25. Strohmeyer T, Peter S, Hartmann M, et al. Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumours. Cancer Res 1991; 51: 1811-6.
26. Rajpert-Demeyts E, Skakkebæk NE. Expression of the ckit protein product in carcinoma in situ and invasive germ cell tumour. Int J Androl 1994; 17: 85-92.
27. Rajpert-Demeyts E, Bartkova J, Samson M, et al. The emerging phenotype of the testicular carcinoma in situ germ-cell. APMIS 2003; 111: 267-78.
28. Skakkebæk NE, Berthelsen JG, Givercman A, Müller J. Carcinoma in situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumour except spermatocytoma. Int J Androl 1987; 10: 19-28.
29. Dieckmann KP, Skakkebæk NE. Carcinoma in situ of the testis: review of biological and clinical features. Int J Cancer 1999; 83: 815-22.
30. Donner J, Kliesch S, Brehm R, Bergmann M. From carcinoma in situ to germ cell tumour. APMIS 2004; 112: 79-88.
31. Kliesh S, Behre HM, Hertle L, Bergmann M. Alteration of Sertoli cell differentiation in the presence of carcinoma in situ in human testes. J Urol 1998; 160: 1894-8.
32. Kang JL, Rajpert-Demeyts E, Giwercman A, Skakkebæk NE. The association of testicular carcinoma in situ with intratubular mirocalcifications. J Urol Pathol 1994; 2: 235-42.
33. Fink, Weigel R, Hembes T, et al. Altered expression of ZO-1 and ZO-2 in Sertoli cell and loss of blood-testis integrity in testicular carcinoma in situ. Neoplasia 2006; 8 (12): 1019-27.
34. Moroi S, Saitou M, Fujimoto K, et al. Occludin is concentrated at tight junction of mouse/rat but not human/guinea in Sertoli cells in testes. Am J Physiol 1998; 274: (6 Pt 1) C1708-C1717.
35. Wong C, Mruk DD, Lui W, Cheng CY. Regulation of blood-testis dynamics: an in vivo study. J Cell Sci 2004; 117: 783-98.
36. Schmoll HL, Souchon R, Krege S, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15: 1377-99.
37. Rørth M, Rajpert-Demeyts E, Andersson L, et al. Carcinoma in situ of the testis. Scand J Urol Nephrol Suppl 2000; 205: 166-86.
38. Almstrup K, Leffers H, Lothe RA, et al. Improved gene espression signature of testicular carcinoma in situ. Int J Androl 2007; 30: 292-303.
39. Daugaard G, Rørth M, von del Maase H, Skakkebæk NE. Management of extragonadal germ cell tumours and the significance of bilateral testicular biopsies. Ann Oncol 1992; 3: 283-9.
40. Holstein AF, Lauke H. Histologic diagnostics of early testicular germ-cell tumour. Int J Urol 1996; 3: 165-72.
41. Dieckmann KP, Loy V. False-negative biopsies for the diagnosis of Testicular Intraephitelial Neoplasia (TIN) - An update. Eur Urol 2003; 43: 516-21.
42. Dieckmann KP, Souchon Rhahn E, Loy V. False negative biopsies for testicular intraephitelial neoplasia. J Urol 1999; 162: 364-8.
43. Van Casteren NJ, de Jong J, Stoop H, et al. Evaluation of testicular biopsies for carcinoma in situ: immunohistochemistry is mandatory. Int J Androl 2008; Sep 16 [Epub ahead of print].
44. Hoei-Hansen CE, Olsen IA, Joergensen N, et al. Current approaches for detection of carcinoma in situ testis. Int J Androl 2007; 30: 398-405.
45. De Jong, Looijenga LH. Stem cell marker OCT3/4 in tumour biology and germ cell tumour diagnostics: history and future. Crit Rev Oncog 2006; 12: 171-203.
46. De Jong, Stoop H, Dohle GR, Bangma CH, et al. Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumour. J Pathol 2005; 206: 242-9.
47. Van Casteren N, Stoop H, Dohle GR, de Wit R, Osterhuis JW, Looijenga LH. Noninvasive detection of testicular carcinoma in situ in semen using OCT3/4. Eur Urol 2008; 54: 153-60.
48. Ho GT, Gardner H, De Wolf WC, Loughlin KR, Morgentaler A. Influence of testicular carcinoma on ipsilateral spermatogenesis. J Urol 1992; 148: 821-5.
49. Petersen PM, Giwercman A, Hansen SW, et al. Impaired testicular function in patients with carcinoma-in-situ of the testis. J Clin Onc 1999; 17 (1): 173-9.
50. Huyghe E, Soulie M, Escorru G, Mieusset R, Plante P, Thonneau P. Conservative management of small testicular tumours relative to carcinoma in situ prevalence. J Urol 2005; 173: 820-3.
51. Von der Maase H. Clinical aspect of carcinoma in situ testis. Concluding remarks. Eur Urol 1993; 23: 251-2.
52. Seldmayer F, Höltl W, Kozak W, et al. Radiotherapy of testicular intraepithelial neoplasia (Tin): a novel treatment regimen for a raredisease. Int J Rad Oncol Biol Phis 2001; 50 (4): 909-13.
53. Izard MA. Leydig cell function and radiation. A review of literature. Radiother Oncol 1995; 34: 1-8.
54. Petersen PM, Giwercman C, Daugaard, et al. Effect of graded testicular doses of radiotherapy in patients treated for carcinoma in situ in the testis. J Clin Oncol 2002; 20: 1537-43.
55. Classen J, Dieckmann KP, Bamberg M, et al. Radiotherapy with 16 Gy may fail to eradicate testicular intraepithelial neoplasia (TIN): preliminary communication of a dose-reduction trial of the German Testicular Cancer Study Group. Br J Cancer 2003; 88: 828-31.
56. Von Ostau C, Krege S, Hartmann M, Rübren H. Metachronous contralateral germ cell tumour 7 years after management of testicular intraepithelial neoplasia by chemotherapy and multiple control biopsies. Scand J Urol Nephrol 2001; 35: 430-1